X

Vous n'êtes pas connecté

Maroc Maroc - NEWS.MEDICAL.NET - A la Une - 10/Jul 19:14

Antibody fragment discovery could lead to much-needed treatment for light chain amyloidosis

In people with a rare condition called light chain amyloidosis, light chain proteins-;which are a component of antibodies-;mutate and build up in different organs.

Articles similaires

Making Heart Transplants Safer With Antibodies

medindia.net - 14/Aug 12:54

Transplanted hearts functioned longer in mice when the recipients who received the organs were administered with the novel antibody treatment before...

New anti-CKAP4 antibodies deliver hope for pancreatic cancer treatment

oncologynews.com.au - 14:10

Pancreatic cancer is an aggressive disease with few available treatments. Thankfully, researchers are hard at work to improve treatment options, and...

AIDS Response Caught In A Debt Trap – OpEd

eurasiareview.com - 14/Aug 11:54

When countries are unable to repay debts, domestic financing for health, education or social protection gets slashed which disproportionately...

$11.5m development application could lead to more than 100 new homes

nynganobserver.com.au - 12/Aug 21:00

It will contribute to the 'much-needed housing opportunities'.

BMW stops deliveries: Thousands of cars stuck in showrooms

thewest.com.au - 09:00

BMW is holding back thousands of cars from customers, following the discovery of a fault which could lead to reduced braking performance.

Sorry! Image not available at this time

BMW stops deliveries: Thousands of cars stuck in showrooms

carexpert.com.au - 08:00

BMW is holding back thousands of cars from customers, following the discovery of a fault which could lead to reduced braking performance.

Study suggests an MRI may help doctors predict more aggressive prostate cancer in patients

oncologynews.com.au - 19/Aug 13:30

Corewell Health research suggests an MRI scan can help predict whether patients with intermediate-risk prostate cancer (cancer confined to the entire...

Sorry! Image not available at this time

Galderma Receives U.S. FDA Approval for Nemluvio® (nemolizumab) for Adult Patients Living With Prurigo Nodularis

financialpost.com - 13/Aug 05:05

Ad hoc announcement pursuant to Art. 53 LR Nemluvio® (nemolizumab) is the first approved monoclonal antibody specifically inhibiting the signaling of...

Signs, symptoms, risk factors of sepsis

newsday.co.tt - 13/Aug 05:37

Dr Maxwell Adeyemi SEPSIS IS the body’s extreme response to an infection. It is a condition that arises when the body’s response to an infection...

Bombshell secret training videos detail how a second Trump administration would operate

rawstory.com - 10/Aug 12:21

Reporting HighlightsDEEP STATE BATTLE: Project 2025’s plan to train an army of political appointees who could fight the so-called deep state on...

Les derniers communiqués

  • Aucun élément